Guangzhou, China

Zhihui Liao

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Daan Gene Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhihui Liao. Retrieved from https://idiyas.com/inventor/zhihui-liao-vapf986v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zhihui Liao: Innovator in COVID-19 Detection Technology

Introduction

Zhihui Liao is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of medical diagnostics, particularly in the detection of novel coronavirus. His innovative work has been crucial during the global pandemic.

Latest Patents

Zhihui Liao holds a patent for the "RT-PCR Detection Method and Kit for Novel Coronavirus." This invention plays a vital role in the rapid and accurate detection of COVID-19, aiding in public health efforts.

Career Highlights

Liao is associated with Daan Gene Co., Ltd., a company known for its advancements in genetic testing and diagnostics. His work at the company has positioned him as a key figure in the fight against infectious diseases.

Collaborations

Zhihui Liao has collaborated with notable colleagues, including Jian Fan and Xiwen Jiang. Their combined expertise has contributed to the development of effective diagnostic tools.

Conclusion

Zhihui Liao's contributions to medical technology, particularly in the realm of COVID-19 detection, highlight his importance as an inventor. His work continues to impact public health positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…